Point72 Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Point72 Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-130,850	Closed	-$5.51M	–	2991
2023 Q2	$5.51M	Sell	130,850 -583,402	-82%	-$23.6M	0.02%	788
2023 Q1	$25.4M	Buy	+714,252	New	+$25.9M	0.08%	292
2022 Q4	–	Sell	-244,500	Closed	-$11.5M	–	1872
2022 Q3	$11.5M	Sell	244,500 -336,783	-58%	-$21.8M	0.05%	470
2022 Q2	$41.7M	Buy	581,283 +160,183	+38%	+$11.7M	0.18%	157
2022 Q1	$34.1M	Sell	421,100 -374,179	-47%	-$31.7M	0.14%	205
2021 Q4	$81.7M	Buy	795,279 +606,179	+321%	+$58.2M	0.33%	61
2021 Q3	$16.5M	Buy	189,100 +84,600	+81%	+$7.66M	0.07%	359
2021 Q2	$9.35M	Buy	104,500 +58,499	+127%	+$4.94M	0.04%	468
2021 Q1	$3.49M	Sell	46,001 -123,499	-73%	-$9.31M	0.02%	642
2020 Q4	$11.5M	Buy	+169,500	New	+$10.6M	0.06%	409
2020 Q3	–	Sell	-707,612	Closed	-$41.2M	–	1143
2020 Q2	$41.2M	Buy	+707,612	New	+$38M	0.27%	94
2019 Q3	–	Sell	-367,976	Closed	-$18.8M	–	1547
2019 Q2	$18.8M	Buy	+367,976	New	+$17.1M	0.1%	260
2018 Q4	–	Sell	-318,800	Closed	-$16.4M	–	1287
2018 Q3	$16.4M	Sell	318,800 -212,000	-40%	-$10.4M	0.07%	347
2018 Q2	$24.9M	Buy	530,800 +33,200	+7%	+$1.37M	0.1%	250
2018 Q1	$17.7M	Buy	497,600 +256,200	+106%	+$10M	0.07%	315
2017 Q4	$10.5M	Sell	241,400 -356,639	-60%	-$16.7M	0.05%	435
2017 Q3	$31.3M	Buy	598,039 +556,439	+1,338%	+$31M	0.14%	182
2017 Q2	$2.43M	Sell	41,600 -451,518	-92%	-$23.5M	0.01%	619
2017 Q1	$22.6M	Buy	493,118 +490,618	+19,625%	+$24.4M	0.13%	224
2016 Q4	$132K	Sell	2,500 -215,100	-99%	-$10.4M	﹤0.01%	658
2016 Q3	$9.7M	Buy	217,600 +175,300	+414%	+$7.6M	0.07%	282
2016 Q2	$1.61M	Buy	+42,300	New	+$1.86M	0.01%	582
2016 Q1	–	Sell	-96,900	Closed	-$4.7M	–	885
2015 Q4	$4.7M	Buy	96,900 +86,200	+806%	+$3.83M	0.04%	419
2015 Q3	$428K	Buy	+10,700	New	+$467K	﹤0.01%	658

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Asset Management's SYNH Position: Q3 2023 in Review

Point72 Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 130,850 shares — an estimated $5.51M sold.

Point72 Asset Management first reported a position in SYNH in Q3 2015 and held it in 24 quarters. The position peaked at $81.7M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Point72 Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Point72 Asset Management sold 130,850 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $5.51M.
Point72 Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 24 quarters.
Point72 Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $81.7M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.